UCI-1
UCI-1 is a SARS-CoV-2 main protease (Mpro) cyclic peptide inhibitor with an IC50 of 160 μM. UCI-1 shows no obvious cytotoxicity at the concentration of inhibiting Mpro. UCI-1 can be used in the study of anti-COVID-19 drugs.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C33H45N7O7
- Masse moléculaire:651.75
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
IC50 & Target
IC50: 160 μM (SARS-CoV-2 Mpro)[1]
Chemical Information
-
Masse moléculaire 651.75
-
Formule C33H45N7O7
-
Sequence
cyclo(Lys-Ser-Gln-Phe-{AEPA})
-
Sequence Shortening
cyclo(KSQF-{AEPA})
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)